Etravirine 80005-0113
Product NDC
80005-0113- Manufacturer
- Carnegie Pharmaceuticals Llc
- Dosage Form
- Tablet
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- June 7, 2022
- Listing Expires
- December 31, 2026
- Application
- ANDA215402
Need to source Etravirine? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Etravirine | 200 mg/1 |
Drug Class
Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]Cytochrome P450 2C19 Inhibitors [MoA]Cytochrome P450 2C9 Inhibitors [MoA]
Packaging Options(1)
60 TABLET in 1 BOTTLE (80005-113-09)